Delivering Value for All Health Care Stakeholders. Larry Merlo President & Chief Executive Officer

Similar documents
Growth in an Evolving Health Care Market

Meeting the Health Care Challenges of Tomorrow. Jon Roberts Executive Vice President & President, CVS Caremark

Fourth Quarter 2018 Earnings Conference Call

Third Quarter 2017 Earnings Conference Call

Unique PBM Capabilities

Fourth Quarter 2016 Earnings Conference Call

Fourth Quarter 2017 Earnings Conference Call

Q Formulary Performance:

Second Quarter 2017 Earnings Conference Call

Evolving Health Care Market

36 th Annual J.P. Morgan Healthcare Conference January 9, Bruce D. Broussard President & CEO

CVS HEALTH/AETNA INVESTOR CALL SCRIPT

Earnings Conference Call

June Investor Presentation

Earnings. Larry Merlo. President & Chief Executive Officer. Executive Vice President & Chief Financial Officer. November 4, 2014

2018 Guidance Conference Call

THANK YOU SPONSORS 2

Insightsfeature. Managing Specialty Drug Spend Under the Medical Benefit. Innovations and Automation for More Effective Management.

CWAG Prescription Drug Pricing Webinar

(401) (212) FOR IMMEDIATE RELEASE CVS HEALTH REPORTS FOURTH QUARTER AND FULL YEAR RESULTS AND PROVIDES 2019 FULL YEAR GUIDANCE

At the heart Annual Report. of health.

BERKELEY RESEARCH GROUP. Executive Summary

KEEPING PRESCRIPTION DRUGS AFFORDABLE: The Value of Pharmacy Benefit Managers (PBMs)

PRESCRIPTION DRUG SPENDING IN THE U.S. HEALTH CARE SYSTEM: AN ACTUARIAL PERSPECTIVE

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

MEDICARE ADVANTAGE MA Plans. to $28 per month 46% HOW HEALTH SYSTEMS CAN THRIVE WITH. Developing Your Medicare Advantage Strategy PRODUCT

Trends disrupting pharmacy value pools and potential implications for the value chain

Disease Management and the Medicare Drug Benefit: Opportunities and Threats for the Pharmaceutical Industry

Marc Claussen, Chiesi USA, Director, Market Access. Donna White, Chiesi USA, Sr. Director, Contracting and Compliance

Brian Bertha VP, Corporate Strategy and Business Development McKesson U.S. Pharmaceutical

Standing strong for payers and patients

CBI 4th Reimbursement and Contracting Conference: Key Challenges Related to Specialty Drug Pricing and Contracting

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

Standing strong for payers and patients

Moving From Offers to Solutions

1 sur 10 03/02/ :56

PhRMA Perspective: Government Policies to Support Innovative Contracting Approaches

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

Future Trends in Employment, Health and Labor

Employee Benefit Trends and Strategies

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR EMPLOYERS

SelectHealth Prescriptions

Investor Nancy Christal Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (914) (401)

Understanding Pharmacy Benefit Management Services

The Health Insurance Market in Virginia. Maureen Dempsey, MD, MSc, ACC, FAAP Anthem Blue Cross and Blue Shield June 8, 2017

Problems with Current Health Plans

Today PBMs control the pharmacy benefits of more than 253 MILLION Americans.

Today PBMs control the pharmacy benefits of more than 253 MILLION. 3 PBMs. Americans.

Payer Channel Forecasting and Analysis. Patrick J. Park, PharmD, MBA Director, Business Decision Support Daiichi Sankyo, Inc.

Avalere Health 2015 Industry Outlook

J.P. Morgan Healthcare Conference

INDUSTRY TRENDS IN PHARMACY REIMBURSEMENT

National Grid Retiree Club Meeting Long Island. October 2, 2017

Health Insurance Reimbursement: The Good, The Bad and The Ugly. By Terry Bauer, CEO, Specialdocs Consultants

DIR: Trends, Issues, and Impending Impacts

JP Morgan 27th Annual Healthcare Conference Angela F. Braly President & Chief Executive Officer January 12, 2009

UnitedHealth Group Fourth Quarter 2016 Results Teleconference Prepared Remarks January 17, 2017

UnitedHealth Group Third Quarter 2017 Results Teleconference Prepared Remarks October 17, 2017

Sanford C. Bernstein Twenty-Second Annual Strategic Decisions Conference 2006

Magellan Health: Innovating for Profitable Growth. Jefferies 2015 Healthcare Conference June 2, 2015

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

CDHP Special Administration

A VISIBLY DIFFERENT APPROACH TO PHARMACY BENEFITS FOR GOVERNMENT

The Real Deal About Real-Time Benefits. Proven Savings with Up-to-the-Minute, Member-Specific Information Across Multiple Points of Care

Lindsey Imada, PharmD Candidate 2016 Midwestern University, Chicago College of Pharmacy

Pay for Performance & the Changing Landscape for Pharmacy: A Panel Discussion

What to Expect for Pharmacy Benefits and Drug Cost Trends for 2018 & 2019

Raymond James 37 th Annual Institutional Investors Conference. March 8, 2016

TESTIMONY OF CHARLES ROTHBERG, MD IMMEDIATE PAST PRESIDENT MEDICAL SOCIETY OF THE STATE OF NEW YORK

Powering healthcare provider success

Pharmacy Program Management: Pitfalls, Challenges, and Best Practices About Solid Benefit Guidance specialty 60,000,000 covered member lives INSIDER

City of Paterson Selection of Medical, Dental and Prescription Benefit Vendors

37 th Annual J.P. Morgan Healthcare Conference January 9, 2019

A Unique Vision of Care. Jefferies 2014 Global Healthcare Conference June 3, 2014

WHITE PAPER How Consumer-Driven Healthcare Can Drive Down Costs for Payers

How the Blueprint Policy Statement to Lower Drug Costs and Reduce Out-of- Pocket Costs May Affect Employers

Insights into pharmacy benefit management, drug trend and the future

Diplomat s Acquisition of LDI Integrated Pharmacy Services. Nov. 15, 2017

The Declining Value of Payer Access: Defining and improving Rebate Efficiency in the current healthcare landscape

GENERIC DRUG SAVINGS IN THE U.S.

CIGNA AND EXPRESS SCRIPTS: EXPANDS GROWTH OPPORTUNITIES IMPROVES AFFORDABILITY CREATES DIFFERENTIATED SHAREHOLDER VALUE

Savings Generated by New York s Medicaid Pharmacy Reform

Pharmacy Benefit Managers (PBMs)

Access, Quality & Transparency: The Forgotten Issues in the Healthcare Debate Presented at WCIF Benefits Summit April 19, 2017

CVS HEALTH CORP FORM 10-K. (Annual Report) Filed 02/11/14 for the Period Ending 12/31/13

Medicare Modernization Act (MMA)

ECONOMIC PRINCIPLES IMPACTING MANAGED CARE PHARMACY. Adrian Washington PharmD., MBA Vice President of Client Management United Healthcare OptumRx

SilverScript & Aetna Acquisition: Individual Medicare Sales Agent FAQs

Session 75 OF, Advantages & Challenges for Provider Led Health Plans. Moderator: LuCretia Leola Hydell, ASA, MAAA

Based on 5 day Volume Weighted Average Price ending December 1, 2017 of $74.21 per share.

Medicaid in a Time of Historic Change: Prescription Drugs and Costs A Medicaid Perspective

UnitedHealth Group Fourth Quarter and Year End 2014 Results Teleconference Prepared Remarks January 21, Moderator:

THE FAST AND THE FURIOUS REVENUE CYCLE (A.K.A.) THE REVENUE CYCLE OF THE FUTURE

2009 UBS Healthcare Services Conference

Cody Wiberg, Pharm.D., M.S., R.Ph. Executive Director Minnesota Board of Pharmacy

Investor Mike McGuire Media Carolyn Castel Contact: Senior Vice President Contact: Vice President (401) (401) FOR IMMEDIATE RELEASE

Regulatory/Legislative Update

Pharmacy Benefit Managers Overview

November 2017 Follow the Dollar

Transcription:

Delivering Value for All Health Care Stakeholders Larry Merlo President & Chief Executive Officer

Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health Care Market How We ll Drive Long-Term Enterprise Growth 2

The Most Extensive Suite of Leading Assets Retail Clinics Long-Term Care Retail Cost Management Tools Mail Specialty Clinical Programs Infusion Digital Payors Patients Providers Medical Claims Editing enabling us to deliver superior outcomes at a lower cost 3

Our Integrated Model Drives More Affordable, Accessible and Effective Care Proprietary Programs Maintenance Choice Specialty Connect Pharmacy Advisor Appropriate Utilization, Better Outcomes Higher penetration rates of programs, resulting in better outcomes Health Engagement Engine Clinical rules engine with powerful analytical capabilities, providing realtime, actionable information Full View of Patient Enabling single patient record and simplicity of single digital platform to manage all prescriptions 4

Traditional Competitor Touchpoints Are Limited Retail Pharmacy Competitors Health Systems Providers Patients Senior Living Employers Government Health Plans 5

Traditional Competitor Touchpoints Are Limited PBM Competitors Health Systems Providers Patients Senior Living Employers Government Health Plans 6

Our Suite of Assets Provides Touchpoints Across All Health Care Stakeholders Health Systems Providers Patients Senior Living Employers Government Health Plans 7

Our Competitive Advantage: Premier company with the ability to impact patients, payors and providers with innovative, channel-agnostic solutions Deep clinical expertise and insights enable us to help deliver superior outcomes at a lower cost Unmatched CVS Pharmacy value proposition for all payors Broadest specialty capabilities to holistically manage patients in growing market Leading pharmacy provider in long-term care, enabling broader patient reach across the care continuum Site-of-care management capabilities to move patients to more cost-effective sites Largest retail clinic operator, providing convenient, cost-effective care Unparalleled scale in the U.S. making us a low-cost provider 8

Continued Selling Season Success More than $40 billion in gross wins over past five years, with client retention of 96% to 97% Refer to endnotes for additional information. 9

Fueling Growth in PBM Lives and Enterprise Volume PBM Lives Under Management (millions) Enterprise Rx Volume (Rx dispensed, millions) 62 68 72 80 89 1,045 1,075 1,170 1,360 1,380 2013 2014 2015 2016E 2017E 2013 2014 2015 2016E 2017E Refer to endnotes for additional information. 10

Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health Care Market How We ll Drive Long-Term Enterprise Growth 11

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 12

Growth in Health Care and Pharmacy Spend Projected to Outpace GDP Growth T R E N D M A N A G E M E N T Annual Growth Rate (%, 2015-2025) Drivers of Trend 4.5% 5.8% 6.7% Increased utilization Growing prevalence of chronic disease Rising prescription costs Growth in specialty Gross Domestic Product Health Expenditures Prescription Drug Expenditures Drug price inflation Refer to endnotes for additional information. 13

Clients Continue to Value PBMs as an Indispensable Solution to Rising Costs T R E N D M A N A G E M E N T Clients Top Rated Cost Control Methods Pharmacy Management Techniques 68% Increased Employee Cost-Sharing Initiatives to Improve Well-Being Full Replacement CDHP Disease/Condition Management 34% 34% 31% 30% Refer to endnotes for additional information. 14

Suite of Capabilities Improving Health Care Affordability T R E N D M A N A G E M E N T Cost Management Solutions Utilization Management Formulary Management Site-Of-Care Management Medical Claims Editing Cost management solutions have lowered client trend to Network Strategies Real-Time Surveillance 3.3% Generic Programs Clinical Programs Refer to endnotes for additional information. 15

Mitigated Branded Price Increases With Cost Management Solutions 9.3% 10.0% Branded Rx Price Growth (total market, IMS Health) 11.5% 14.3% T R E N D M A N A G E M E N T 12.4% 8.7% 9.1% 4.9% 5.1% 2.8% 2011 2012 2013 2014 2015 Gross Net Refer to endnotes for additional information. 16

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 17

Government Accounts for Two-Thirds of Health Insurance Spending G O V E R N M E N T Government Health Insurance Spend ($, trillions) 1.6 2.1 2.9 Key Drivers Growth in government programs Medicare Medicaid % of insurance spend 2015 2020E 2025E 66% 67% 68% These businesses are lower margin, but have higher utilization Refer to endnotes for additional information. 18

Demand for Cost-Effective Care Will Remain Despite Uncertainty Around Health Care Reform G O V E R N M E N T U.S. Uninsured Rate Future Outlook 14.3% 11.2% 8.3% Many unknowns around repeal and replace Some ACA policies could remain, while others could change Need for coverage expected to remain 2012 2014 2016E CVS Health can pivot to address policy changes with the right solutions Refer to endnotes for additional information. 19

CVS Health Well-Positioned to Capitalize on Growth in Medicare G O V E R N M E N T 54.0 Medicare Enrollment (lives, millions) 62.6 71.6 2015E 2020E 2025E CVS Health Advantages CVS Caremark: 12 million total Med D members SilverScript is the largest PDP with 5.6 million members Also support Med D/MAPD offerings of more than 40 health plans CVS Pharmacy: Medicare represents 23% of prescriptions dispensed Omnicare is a leading pharmacy provider in the long-term care market Refer to endnotes for additional information. 20

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 21

Movement Towards Value-Based Care Creates Need for New Cost Management Solutions V A L U E - B A S E D C A R E Provider Reimbursements Tied to Value 45% Today ~60% 5 Years From Now Despite the anticipated shift of reimbursement to valuebased payments, only 26% of providers are currently meeting their goals to lower health care costs Expectation is that value-based care will be key determinant of success Refer to endnotes for additional information. 22

V A L U E - B A S E D C A R E Multitude of Ways We Provide Cost-Effective Care Pharmacy Care MinuteClinic Infusion Care Transitions Med D Star Ratings Clinical Programs Unique integrated programs, 90-day programs, formulary designs and value-based contracting Providing health care services, including wellness and chronic care support Home or alternate-site infusion services can dramatically lower costs Avoiding costly hospital readmissions by preventing lapses in adherence Driving Med D Star ratings through clinical capabilities Powered by Health Engagement Engine and brought to life through face-to-face interactions 23

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 24

Unsurpassed Procurement Scale Through Enterprise Dispensing Volume S I Z E A N D S C A L E 2016 Estimated Rx Volume (Rx dispensed, millions) Walgreens Express Scripts Aetna + Humana Anthem + Cigna OptumRx 140 120 100 350 930 1,360 CVS Health Advantages Unsurpassed scale and expertise allows us to be an efficient purchaser of pharmaceuticals Procurement scale further enhanced by Red Oak Sourcing Refer to endnotes for additional information. 25

Ability to Aggregate Claims Volume Creates Value for Clients S I Z E A N D S C A L E 2016 Estimated Claims Volume (Rx managed, millions) Express Scripts OptumRx Aetna + Humana Anthem + Cigna 500 650 1,000 1,385 1,275 CVS Health Advantages Managed claims volume supports negotiations for: Rebates Price protection Formulary placement More than 90% of rebates overall are passed back to clients Competition in drug classes allows us to utilize scale more effectively Refer to endnotes for additional information. 26

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 27

R E T A I L I Z A T I O N O F H E A L T H C A R E Consumer-Directed Health Plans Gaining Traction 62% CDHP Prevalence (% of large employers) 84% 92% Drivers of Trend Employers looking to better control rising health care costs Health insurance shoppers on public exchanges choosing CDHPs Seek new, trusted health care advisors 2010 2013 2016E 2019E Offered Offered/Considering As member cost burden increases, mindset shifting from patient to consumer Refer to endnotes for additional information. 28

R E T A I L I Z A T I O N We Own the Last Mile of Care Through Our Unmatched Patient Touchpoints O F H E A L T H C A R E Specialty Retail Clinics Mail Long-Term Care Retail Pharmacy Infusion No matter the road, we can shape behavior and drive outcomes 29

We See Compelling Opportunities in a Robust Health Care Market 1 2 3 4 5 6 Focus on Trend Management Evolving Role of Government in Health Care Movement to Value-Based Care Slow, But Inevitable Ongoing Benefits of Size and Scale Increasing Consumerism / Retailization of Health Care Growing Role of Digital 30

CVS Health Digital Strategy Focused on Three Pillars D I G I T A L Adoption Attract new users Increase engagement of active digital users Integrated CVS Health Experience Core pharmacy Specialty Long-term care Omnichannel front store MinuteClinic Ongoing Innovation Mobile engagement Data & personalization Digital health Enhance customer experience, drive loyalty and improve outcomes 31

Agenda Our Value Proposition Has Never Been Stronger We See Compelling Opportunities in a Robust Health Care Market How We ll Drive Long-Term Enterprise Growth 32

Our Strategic Business Imperatives Aggregate Lives Grow Share Execute With Excellence Drive Innovation Enterprise Focus Actions to achieve growth may change, strategic imperatives remain 33

Actions to Capitalize on Market Dynamics New, Innovative PBM Products Enterprise Streamlining Initiative Partner More Broadly Sustainable Enterprise Growth Return Value to Shareholders 34

Actions to Capitalize on Market Dynamics Partner More Broadly New, Innovative PBM Products Enterprise Streamlining Initiative Key Actions Utilize full suite of enterprise capabilities to enhance CVS Pharmacy value proposition Bundled service offerings Will make us partner of choice Partner More Broadly Sustainable Enterprise Growth Return Value to Shareholders Clinical capabilities a competitive edge in value-based care New strategic relationship with Optum 35

Actions to Capitalize on Market Dynamics New, Innovative PBM Products New, Innovative PBM Products Enterprise Streamlining Initiative Key Actions Clinical solutions to support all stages of care Value-based contracting approaches Partner More Broadly Sustainable Enterprise Growth Return Value to Shareholders New retail network strategies, including performance-based networks Maintenance Choice 3.0 Ongoing innovations 36

Actions to Capitalize on Market Dynamics Enterprise Streamlining Initiative New, Innovative PBM Products Enterprise Streamlining Initiative Key Actions Further improve productivity to solidify low cost provider status Three broad areas of focus: Store rationalization Partner More Broadly Sustainable Enterprise Growth Return Value to Shareholders Enhance efficiency of corporate shared services Optimize pharmacy delivery platform Expect to generate nearly $3 billion in cumulative savings by 2021 37

Actions to Capitalize on Market Dynamics Return Value to Shareholders New, Innovative PBM Products Enterprise Streamlining Initiative Key Actions Optimize use of capital to drive shareholder returns Continue to evaluate strategic opportunities to drive long-term growth Partner More Broadly Sustainable Enterprise Growth Return Value to Shareholders Annual dividend increases Share repurchases 38

Today s Key Takeaways Driving More Affordable, Accessible and Effective Care Driving Outcomes and Savings Providing the Front Door and the Last Mile Best Partner for PBMs and Health Plans Integrated Pharmacy Care Positioned for L-T Enterprise Growth In an era of rising costs, we are the optimal partner to deliver savings and help improve outcomes for health care stakeholders Pharmacy has the highest frequency of interaction, and our unmatched patient touchpoints across the enterprise help shape behavior We can partner with all PBMs and health plans, leveraging our enterprise assets and capabilities to meet their individual needs Our exclusive programs are seamlessly integrated through our Health Engagement Engine, providing better member experience and results Maximize shareholder value with an enterprise mindset; generate strong cash flow and employ a disciplined approach to capital allocation Delivering Value for All Health Care Stakeholders 39

Endnotes Slide 9 1. As of December 2, 2016. 2. Gross new business revenues exclude Medicare Part D SilverScript individual products. 3. Client retention rate is defined as: 1 less (estimated lost revenues from any known terminations in that selling season year plus annualization of any mid-year terminations, divided by estimated PBM revenues for that selling season year) expressed as a percentage. Both terminations and PBM revenues exclude Medicare Part D SilverScript individual products. Slide 10 1. Enterprise dispensed Rx include prescriptions filled at CVS Pharmacy, mail order and specialty prescriptions filled at CVS Caremark, and prescriptions filled by our long-term care pharmacies. 2. All dispensed CVS retail and mail prescriptions include the adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal 30-day prescription. 3. Source: CVS Health internal analysis. Slide 13 1. Source: CMS, National Health Expenditure Projections (figures as of July 14, 2016). Slide 14 1. Source: National Business Group on Health, 2017 Large Employers Health Plan Design Survey, Figure 11. 40

Endnotes Slide 15 1. Source: CVS Health internal data analysis. 2. Utilization trend based on internal commercial cohort (Health Plans and Employers). 3. Trend is reported net of rebates. Slide 16 1. Source: IMS Institute for Healthcare Informatics, Medicines Use and Spending in the U.S., Chart 3. Slide 18 1. Source: McKinsey proprietary research. 2. Includes Medicare, Medicaid, and other federal, state programs (e.g. Children s Health Insurance Program, Department of Veterans Affairs, Department of Defense). Slide 19 1. Source: CMS, National Health Expenditure Projections, Table 17: Health Insurance Enrollment and Enrollment Growth Rates, Calendar Years, 2009-2025 (figures as of July 14, 2016). Slide 20 1. Source: CMS, National Health Expenditure Projections, Table 17: Health Insurance Enrollment and Enrollment Growth Rates, Calendar Years, 2009-2025 (figures as of July 14, 2016). 2. Source: CMS (membership figures as of October 7, 2016). Slide 22 1. Source: McKesson, Journey to Value: The State of Value-Based Reimbursement in 2016, Figure 8. 2. Reimbursements tied to a value-based payment arrangement based on providers who use other models than 100% feefor-service only. 41

Endnotes Slide 25 1. Enterprise dispensed Rx include prescriptions filled at CVS Pharmacy, mail order and specialty prescriptions filled at CVS Caremark, and prescriptions filled by our long-term care pharmacies. 2. All dispensed CVS retail and mail prescriptions include the adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal 30-day prescription. 3. Source: CVS Health internal data analysis. Slide 26 1. Source: CVS Health internal data analysis. 2. CVS Caremark claims represent midpoint of guidance range. 3. Estimated managed claims include all CVS Caremark network claims plus specialty and adjusted mail claims. 4. All managed CVS Caremark mail prescriptions include the adjustment to convert 90-day prescriptions to the equivalent of three 30-day prescriptions. This adjustment reflects the fact that these prescriptions include approximately three times the amount of product days supplied compared to a normal 30-day prescription. Slide 28 1. Source: National Business Group on Health, 2017 Large Employers Health Plan Design Survey, Figure 5. 42